LEADER 04856nam 2200637Ia 450 001 9910830985803321 005 20221226232417.0 010 $a1-280-74297-6 010 $a9786610742974 010 $a0-470-79050-4 010 $a0-470-98737-5 010 $a1-4051-7237-1 035 $a(CKB)1000000000351286 035 $a(EBL)284282 035 $a(SSID)ssj0000151322 035 $a(PQKBManifestationID)11146928 035 $a(PQKBTitleCode)TC0000151322 035 $a(PQKBWorkID)10317389 035 $a(PQKB)11255893 035 $a(MiAaPQ)EBC284282 035 $a(OCoLC)181343640 035 $a(EXLCZ)991000000000351286 100 $a20040715d2005 fy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEvidence-based respiratory medicine$b[electronic resource] /$fedited by Peter Gibson ... [et al.] 210 $aLondon $cBMJ$d2005 215 $a1 online resource (642 p.) 225 1 $aEvidence-Based Medicine 300 $aDescription based upon print version of record. 311 $a0-7279-1605-X 320 $aIncludes bibliographical references and index. 327 $aEvidence-based Respiratory Medicine; Contents; Contributors; Acknowledgement to Cochrane Library; 1. Practising evidence-based respiratory medicine; 1.1 Introduction; 1.2 Diagnostic strategies; 1.2.1 Presenting symptoms; 1.2.2 Lung function testing; 1.2.3 Chest radiographic and computerized tomography patterns; 1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach; 1.2.5 Screening for lung cancer; 1.3 Therapeutics: general issues; 1.3.1 Adherence and self-management; 1.3.2 Corticosteroid-induced osteoporosis; 1.3.3 Helping people to stop smoking; 2. Asthma 327 $a2.1 Acute exacerbations2.2 Chronic therapy: B-agonists,short-acting,long-acting B2-agonists; 2.3 Inhaled corticosteroids in the treatment of asthma; 2.4 Anti-leukotrienes; 2.5 Asthma education; 2.6 Non-pharmacological and complementary interventions to manage asthma; 2.7 Difficult asthma; 2.8 Novel therapies in asthma: long-acting B2 -agonists/inhaled corticosteroids; 3. Chronic obstructive pulmonary disease; 3.1 Chronic obstructive pulmonary disease -acute exacerbations; 3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy 327 $a3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease3.4 Combination of inhaled corticosteroids and long-acting B2 -agonists in chronic obstructive pulmonary disease; 3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease; 3.6 Lung volume reduction; 4. Infection; 4.1 Bronchitis and sinusitis; 4.2 Community-acquired pneumonia; 4.3 Pulmonary tuberculosis; 4.4 Influenza: vaccination and treatment; 4.5 Bronchiectasis; 4.6 Adult cystic fibrosis; 4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis 327 $a5. Respiratory failure/sleep-disordered breathing5.1 Respiratory rehabilitation; 5.2 Non-invasive ventilation in acute respiratory failure; 5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?; 5.4 The treatment of the obstructive sleep apnoea-hypopnoea syndrome; 5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease; 6. Diffuse lung disease/pleural disease/thromboembolism; 6.1 Diffuse lung disease; 6.1.1 The treatment of cryptogenic fibrosing alveolitis 327 $a6.1.2 Evidence-based approach to the treatment of sarcoidosis6.1.3 Hypersensitivity pneumonitis; 6.2 Pleural disease; 6.3 Therapy of pulmonary thromboembolism: an evidence-based approach; 6.4 Pulmonary hypertension; Index 330 $aFirst major evidence-based text in adult respiratory medicineComprehensive, authoritative summary of the best treatments for the major respiratory diseasesCompiled by specialists from the Cochrane Airways Management GroupEasy-to-use format, with key clinical implications summarised in each chapterKept up-to-date online Compiled by specialists from the Cochrane Collaboration Airways Management Group, Evidence-based Respiratory Medicine is the first major evidence-based text in adult respiratory medicine. Providing a comprehensive summary of the best treat 410 0$aEvidence-Based Medicine 606 $aRespiratory organs$xDiseases 606 $aEvidence-based medicine 615 0$aRespiratory organs$xDiseases. 615 0$aEvidence-based medicine. 676 $a616.2/0046 686 $a44.84$2bcl 701 $aGibson$b Peter$cDr.$0990660 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830985803321 996 $aEvidence-based respiratory medicine$92266772 997 $aUNINA